Investment case
Cellectis S.A.
CLLS · 4 developments mapped · last assessed 2026-09-12
Market Ontology has mapped 4 macro, policy, and market developments to Cellectis S.A. since 2026-09-12. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for CLLS yet, so no modelled value is shown. The CLLS valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run CLLS on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Open question
Cellectis Schedules September 14 Business Update on Gene Editing and CAR T Pipeline
Direct corporate communication and investor relations event. Potential for new data, pipeline updates, strategic announcements, or financial guidance changes.
· Moves probability of success pipeline assets, peak sales estimates, time to market
What changed, by assumption
- 2026-09-12Cellectis Schedules September 14 Business Update on Gene Editing and CAR T Pipeline
- 2026-09-12Cellectis Schedules September 14 Business and CAR T Pipeline Update
- 2026-09-12Cellectis sets September 14 business update on CAR-T and gene editing pipeline
- 2026-09-12Cellectis schedules September 14 webcast to present pipeline business update
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-12 | Cellectis Schedules September 14 Business Update on Gene Editing and CAR T Pipeline | watch | 1-5d | 0.80 |
| 2026-09-12 | Cellectis schedules September 14 webcast to present pipeline business update | watch | 1-5d | 0.70 |
| 2026-09-12 | Cellectis Schedules September 14 Business and CAR T Pipeline Update | watch | 1-5d | 0.80 |
| 2026-09-12 | Cellectis sets September 14 business update on CAR-T and gene editing pipeline | watch | 1-5d | 0.80 |